is tirzepatide safe for liver Effect of Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction‐Associated Steatotic Disease and Type 2 Diabetes Mellitus - Arai - 2025 - Hepatology Research A Rare Case of Tirzepatide-Induced

Rare but Serious Side Effects of GLP-1s In rare instances, the delayed gastric emptying caused by GLP-1 medications can contribute to or exacerbate conditions like: Gastroparesis (Stomach Paralysis): This is a disorder where the stomach muscles move food through the digestive tract very slowly or stop altogether, not due to a physical blockage, but due to impaired nerve function

Una revisione sistematica di 39 RCT su soggetti non diabetici ha confermato un effetto di classe significativo rispetto al placebo: Nausea: 1123% dei pazienti (picco nelle prime settimane di titolazione) Vomito: fino all11,5% Diarrea: 511,5% Stipsi: rischio pi basso rispetto agli altri sintomi Gli eventi avversi gastrointestinali sono la causa principale di interruzione del trattamento

Physiol Rep 2024;12:e16169

Compared with previous studies, our analysis not only reaffirms semaglutide's cardiovascular protective effects in patients with T2DM ( Our study is the first meta-analysis to evaluate semaglutide's impact on cardiovascular outcomes in patients with T2DM and comorbid CVD or CKD, while also comparing the efficacy of subcutaneous vs